Immunosuppressive-activity potentiating compositions

Details Immunosuppressive-activity potentiating compositions Immunosuppressive-activity potentiating compositions

1997-01-17

1999-01-19

Henley, III, Raymond

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Phosphorus containing other than solely as part of an...

A61K 21665

Patent

active

058613846

ABSTRACT:
According to the present invention, there are provided immunosuppressive-activity potentiating compositions which comprise a ##STR1## (R.sub.1 and R.sub.2 are the same or different and represent individually a hydrogen atom or methyl group) or its pharmacologically acceptable salt, and the immunosuppressive-activity potentiating compositions can suppress effectively acute rejection after transplantation.

REFERENCES:
patent: 4564686 (1986-01-01), Ogata
patent: 4888329 (1989-12-01), Ogata et al.
patent: 4914197 (1990-04-01), Yamamoto et al.
patent: 4948786 (1990-08-01), Shimamoto et al.
Transplant. Proc., vol. 25, No. 1, 1993, pp. 610-611, XP000653615, D. Slakey et al.: "Ascorbic acid and alpha-tocopherol prolong rat cardiac allograft survival".

Affiliated with

Also associated with

Rating

Immunosuppressive-activity potentiating compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunosuppressive-activity potentiating compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunosuppressive-activity potentiating compositions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1246734